Learn More
The discovery of a series of genetic and serological markers associated with disease susceptibility and phenotype in inflammatory bowel disease has led to the prospect of an integrated classification(More)
Douglas K. Rex, M.D., John H. Bond, M.D., Sidney Winawer, M.D., Theodore R. Levin, M.D., Randall W. Burt, M.D., David A. Johnson, M.D., Lynne M. Kirk, M.D., Scott Litlin, M.D., David A. Lieberman,(More)